Interestingly, these pathways were also enriched in 22Rv1 cells exposed to CCS1477 [17], suggesting that inhibiting EP300/CREBBP activity through acetyltransferase or BRD elicits similar responses in PCa cells. The gene discussed is CREBBP; the disease is posterior cortical atrophy.